The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Vaccine Safety Forum: Summaries of Two Workshops
11:15–11:45
Detection and Response Activities of Vaccine Manufacturers
Luc Hessel, Pasteur Mérieux Connaught
Robert Levine, Lederle-Praxis Biologicals
Robert Sharrar, Merck Research Laboratories
11:45–12:15 p.m.
Experiences of Consumers with Adverse Event Detection and Response
Barbara Loe Fisher, National Vaccine Information Center
Mark Geier, Medical/Legal Consultant
Kathy Schaus, Little Rock, Arkansas
Jack Sexton, Woodbridge, Virginia
12:15–1:15
LUNCH
IV. Examples of Methodologies Applied to Research on Vaccine Adverse Events
1:15–1:30
Vaccine Lot Surveillance
Susan Ellenberg, Food and Drug Administration
1:30–1:45
Reviewing Case Reports
Frederick Varricchio, Food and Drug Administration
1:45–2:00
Analysis of Seizure Reports in LLDBs
Robert Davis, Group Health Cooperative, Seattle
2:00–2:15
Studying Immune-mediated Disorders
John Martin, University of Southern California School of Medicine
2:15–2:30
BREAK
V. Panel Discussions
2:30–3:15
Panel 1—Reporting and Data Collection
Moderator: Linda Cowan, University of Oklahoma Health Sciences Center
